Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Capricor Therapeutics Inc

CAPR
Current price
6.1 USD +0.09 USD (+1.50%)
Last closed 5.99 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 190 550 880 USD
Yield for 12 month +38.64 %
1Y
3Y
5Y
10Y
15Y
CAPR
21.11.2021 - 28.11.2021

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment of duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs. The company's lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase 3 clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD). It also focused on developing StealthX, an engineered exosome-based vaccine candidate, under phase 1 clinical study for a range of therapeutic applications, including targeted RNA, protein, and small molecule therapeutics to treat or prevent a variety of diseases. In addition, the company develops CAP-2003, under pre-clinical development for the treatment of trauma related injuries and conditions. It has collaboration and distribution agreement with Nippon Shinyaku Co. Ltd., collaboration agreement with National Institute of Allergy and Infectious Diseases, license agreements with the Johns Hopkins University and Cedars-Sinai Medical Center, as well as cell line license agreement with Life Technologies Corporation. The company was founded in 2005 and is headquartered in San Diego, California. Address: 10865 Road to the Cure, San Diego, CA, United States, 92121

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

19.8 USD

P/E ratio

Dividend Yield

Current Year

+25 178 066 USD

Last Year

+2 548 917 USD

Current Quarter

+4 906 877 USD

Last Quarter

+12 088 089 USD

Current Year

+24 109 184 USD

Last Year

+1 854 046 USD

Current Quarter

+4 575 471 USD

Last Quarter

+11 780 481 USD

Key Figures CAPR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -25 053 052 USD
Operating Margin TTM -209.22 %
PE Ratio
Return On Assets TTM -27.66 %
PEG Ratio
Return On Equity TTM -129.63 %
Wall Street Target Price 19.8 USD
Revenue TTM 27 098 248 USD
Book Value 0.73 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 64.3 %
Dividend Yield
Gross Profit TTM 1 746 380 USD
Earnings per share -0.83 USD
Diluted Eps TTM -0.83 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin -89.72 %

Dividend Analytics CAPR

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CAPR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:10
Payout Ratio
Last Split Date 05.06.2019
Dividend Date 05.06.2019

Stock Valuation CAPR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 6.3405
Price Sales TTM 7.8201
Enterprise Value EBITDA -6.9382
Price Book MRQ 8.7115

Financials CAPR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CAPR

For 52 weeks

2.68 USD 8.22 USD
50 Day MA 5.96 USD
Shares Short Prior Month 4 141 573
200 Day MA 4.81 USD
Short Ratio 11.13
Shares Short 4 211 800
Short Percent 15.93 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

430.16 USD Microsoft Corporation +3.16 (+0.74%)
Detailed analytics

ETF funds


S

SX7EEX

14.70 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) +0.1 (+0.64%)
Detailed analytics

Metals


Gold

2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics